Loading...
Loading...
India's citalopram imports from UNITED STATES total $24.9K across 45 shipments from 12 foreign suppliers. AMNEAL PHARMACEUTICALS OF LLC leads with $7.0K in import value; the top 5 suppliers together control 85.4% of this origin. Leading Indian buyers include AMNEAL PHARMACEUTICALS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for citalopram โ a diversified sourcing base with multiple active suppliers from UNITED STATES.

AMNEAL PHARMACEUTICALS OF LLC is the leading Citalopram supplier from UNITED STATES to India, with import value of $7.0K across 29 shipments. The top 5 suppliers โ AMNEAL PHARMACEUTICALS OF LLC, NEW LIFE MEDICALS LLC.,, ESPEE BIOPHARMA & FINECHEM LLC, SUN PHARMACEUTICAL INDUSTRIES INC, SUN PHARMACEUTICAL INDUSTRIES INC. โ collectively account for 85.4% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AMNEAL PHARMACEUTICALS OF LLC | $7.0K | 29 | 28.3% |
| 2 | NEW LIFE MEDICALS LLC., | $6.4K | 1 | 25.7% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC | $3.4K | 1 | 13.7% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES INC | $2.2K | 1 | 8.9% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES INC. | $2.2K | 1 | 8.9% |
| 6 | NEWLIFE MEDICALS (USA). INC. | $1.5K | 2 | 6.1% |
| 7 | NEWLIFE MEDICALS USA INC | $1.1K | 1 | 4.2% |
| 8 | SPRING BIO SOLUTION LIMITED | $489 | 1 | 2.0% |
| 9 | AMNEAL PHARMACEUTICALS | $278 | 1 | 1.1% |
| 10 | GLOBYZ PHARMA LLC | $258 | 1 | 1.0% |
| 11 | AMNEAL PHARMACEUTICAL LLC | $23 | 5 | 0.1% |
| 12 | MS PALESWARA TENNETI | $2 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $7.3K | 35 | 29.5% |
| 2 | MICRO LABS LIMITED | $6.4K | 1 | 25.7% |
| 3 | UMEDICA LABORATORIES PRIVATE LIMITED | $4.5K | 2 | 18.0% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $4.4K | 2 | 17.8% |
| 5 | AUROBINDO PHARMA LTD | $1.5K | 2 | 6.1% |
| 6 | AUROBINDO PHARMA LIMITED | $489 | 1 | 2.0% |
| 7 | JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED | $258 | 1 | 1.0% |
| 8 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $2 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Citalopram suppliers from UNITED STATES to India include AMNEAL PHARMACEUTICALS OF LLC, NEW LIFE MEDICALS LLC.,, ESPEE BIOPHARMA & FINECHEM LLC. The leading supplier is AMNEAL PHARMACEUTICALS OF LLC with import value of $7.0K USD across 29 shipments. India imported Citalopram worth $24.9K USD from UNITED STATES in total across 45 shipments.
India imported Citalopram worth $24.9K USD from UNITED STATES across 45 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Citalopram sourced from UNITED STATES include AMNEAL PHARMACEUTICALS PRIVATE LIMITED, MICRO LABS LIMITED, UMEDICA LABORATORIES PRIVATE LIMITED. The largest buyer is AMNEAL PHARMACEUTICALS PRIVATE LIMITED with $7.3K in imports across 35 shipments.
The total value of Citalopram imports from UNITED STATES to India is $24.9K USD, across 45 shipments and 12 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
45 Verified Shipments
12 suppliers, 8 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists